Diseases, Conditions, Syndromes

Researcher identifies potential cause of 'long COVID'

Even though the COVID-19 public health emergency classification will expire this spring, the lingering effects of the pandemic remain. A constant puzzle to solve since the first year of the pandemic has been "long COVID," ...

Genetics

CRISPR therapeutics can damage the genome

Researchers at Tel Aviv University warn that CRISPR therapeutics can damage the genome. They caution: "The CRISPR genome editing method is very effective, but not always safe. Sometimes cleaved chromosomes do not recover ...

Diseases, Conditions, Syndromes

CAR T cell therapy could reach beyond cancer

Engineered immune cells, known as CAR T cells, have shown the world what personalized immunotherapies can do to fight blood cancers. Now, investigators have reported highly promising early results for CAR T therapy in a small ...

Oncology & Cancer

Cellular 'waste product' rejuvenates cancer-fighting immune cells

A new study by UT Southwestern's Simmons Cancer Center scientists suggests that lactate, a metabolic byproduct produced by cells during strenuous exercise, can rejuvenate immune cells that fight cancer. The finding, published ...

page 6 from 40